Nutrition and Science 2014 concludes on a healthy note
Attended by national and international nutrition experts, it focussed on nutritional requirements for all the age groups and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
IDRI and Jubilant Chemsys extend research for TB drug discovery
The additional grant of $3.4 million will enable development of new drugs to combat tuberculosis
US FDA approves Piramal Imaging’s Neuraceq
Will help in PET imaging of beta-amyloid neuritic plaques in the brain
Urgent action needed to prevent unregulated sale of TB drugs in India: MSF
Strict regulation of first-line TB drug formulations and prescription practices in the private sector is needed in India
Novartis bags approval of Xolair
Xolair is the first and only licensed therapy in the US for the nearly 50 per cent of patients with CIU
Glenmark receives $4 million through Swiss subsidiary
Glenmark Pharmaceuticals has informed the Bombay Stock Exchange that the company through its Swiss subsidiary has received $4…
Medigene signs licence agreement with Falk Pharma
Falk Pharma will initially concentrate on development in primary biliary cirrhosis (PBC)
PHARMA Pro & Pack Expo 2014 to be held in Mumbai
Around 20,000 pharma trade professional/decision makers are likely to attend the event
Industry, regulators in frank discussion at 5th India Pharma Summit
DoP, WHO and FICCI event focused strengthening infrastruture, clarifying regulations pertaining to APIs, drug trials, R&D